
Research highlights: Targeted Protein Degradation in Tauopathies
-1.png)
The status of drug discovery and development for Parkinson's disease

Uncovering ALS pathology and potential drug targets with in vitro iPSC models
-1.png)
The status of drug discovery and development for Alzheimer's disease

Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease

Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs